Japanese drugmaker Shionogi & Co. looks to meet domestic demand, as countries worldwide scramble for supplies of Pfizer and Merck drugs.
If vaccinations should become necessary every year, the government cannot be sending several hundred billion Japanese yen overseas on an annual basis.